Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07201415

Minimally Invasive Suprachoroidal Drainage for the Treatment of Neovascular Glaucoma

An Exploratory Study of the Efficacy and Safety of Minimally Invasive Supraporoidal Drainage for Advanced Neovascular Glaucoma

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Zhongnan Hospital · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

To explore the efficacy and safety of minimally invasive suprachoroidal drainage for the treatment of advanced neovascular glaucoma

Detailed description

To explore the efficacy and safety of minimally invasive supraporcular drainage in the treatment of advanced neovascular glaucoma, and to record the various basic diseases, ocular conditions, lifestyle, inflammatory markers and other parameters of NVG patients. To compare the safety and efficacy of new surgical methods and traditional surgical methods in order to find an effective treatment for neovascular glaucoma

Conditions

Interventions

TypeNameDescription
PROCEDUREminimally invasive suprachoroidal drainageminimally invasive suprachoroidal drainage

Timeline

Start date
2025-01-01
Primary completion
2026-12-31
Completion
2027-03-01
First posted
2025-10-01
Last updated
2025-10-01

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07201415. Inclusion in this directory is not an endorsement.

Minimally Invasive Suprachoroidal Drainage for the Treatment of Neovascular Glaucoma (NCT07201415) · Clinical Trials Directory